Skip to main content

Partial destruction of noradrenergic terminals is followed by increased tyrosine hydroxylase activity in residual terminals

  • Chapter
Function and Regulation of Monoamine Enzymes: Basic and Clinical Aspects

Abstract

Intraventricular administration of 6-hydroxydopamine produced a relatively small decline in tyrosine hydroxylase (TH) activity in rat hippocampus despite the widespread degeneration of central noradrenergic nerve terminals. This increase in the ratio of TH activity to norepinephrine content appeared to result from two temporally distinct processes. At first, within 36 hours after the lesion, the apparent Vmax of TH decreased in parallel to the loss of norepinephrine but there was a marked increase in the affinity of the enzyme for cofactor, resembling the effects of in vitro phosphorylation. Subsequently, this activation of the enzyme declined but the apparent Vmax of TH gradually increased in a manner suggesting an increase in the amount of TH per residual terminal. These short and long term alterations in TH activity after 6-hydroxydopamine treatment may represent adaptive responses to the lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acheson, A.L., Kapatos, G. and Zigmond, M.J. (1981) Life Sci., 28. 1407–1420.

    Google Scholar 

  2. Acheson, A.L., Zigmond, M.J. and Stricker, E.M. (1979) Trans. Amer. Soc. Neurochem., 10, 142.

    Google Scholar 

  3. Acheson, A.L., Zigmond, M.J. and Stricker, E.M. (1980) Science, 207, 537–540.

    Google Scholar 

  4. Acheson, A.L. and Zigmond, M.J. (1981) J. Neurosci., in press.

    Google Scholar 

  5. Buda, M., Roussel, B., Renaud, B. and Pujol, J.F. (1975) Brain Res., 93, 564–569

    Google Scholar 

  6. Cannon, W.B., Newton, H.F., Bright, E.M., Menkin, V. and Moore, R.M. (1929) Amer. J. Physiol., 89, 84–107.

    Google Scholar 

  7. Cedarbaum, J.M. and Aghajanian, G.K. (1976) Brain Res., 112, 413–419.

    Google Scholar 

  8. Gauthier, P., Nadeau, R.A. and deChamplain (1972) Circ. Res., 31, 207–217.

    Google Scholar 

  9. Hornykiewicz, O. (1973) Biochem. Pharmacol., 24, 1061–1065.

    Google Scholar 

  10. Kapatos, G. and Zigmond, M.J. (1979) J. Pharmacol. Exp. Therap., 208, 468–475.

    Google Scholar 

  11. Lloyd, K.G., Davidson, L. and Hornykiewicz, O. (1975) J. Pharmacol. Exp. Therap., 195, 453–464.

    CAS  Google Scholar 

  12. Lloyd, T. and Kaufman, S. (1974) Biochem. Biophys. Res. Commun., 59, 1262–1269.

    Google Scholar 

  13. Morgenroth, V.H., Boadle-Biber, M. and Roth, R.H. (1974) Proc. Natl. Acad. Sci. USA, 71, 4283–4287.

    Google Scholar 

  14. Roth, R.H., Salzman, P.M. and Morgenroth, V.H. (1974) Biochem. Pharmacol., 23, 2779–2784.

    Google Scholar 

  15. Saller, C.F. and Zigmond, M.J. (1978) Life Sciences, 23, 1117–1130.

    Google Scholar 

  16. Stricker, E.M. and Zigmond, M.J. (1976) Progress in Psychobiology and Physiological Psychology Vol. 6, ed. by J.M. Sprague and A.N. Epstein, Academic Press, Inc., New York. pp. 121–188.

    Google Scholar 

  17. Thoenen, H., Mueller, R.A. and Axelrod, J. (1969) J. Pharmacol. Exn. Therap.. 169. 249–254.

    Google Scholar 

  18. Uretsky, N.J. and Iversen, L.L. (1970) J. Neurochem., 17, 269–278.

    Article  CAS  PubMed  Google Scholar 

  19. Zigmond, M.J. and Stricker, E.M. (1974) Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes, ed. by E. Usdin, Raven Press, New York, pp.385–402.

    Google Scholar 

  20. Zigmond, R.E. (1979) J. Neurochem., 32, 23–29.

    Article  CAS  PubMed  Google Scholar 

  21. Zigmond, R.E., Chalazonitis, A., Joh, T. (1981) Neuroscience Letters, 20, 61–65.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1981 The Contributors

About this chapter

Cite this chapter

Zigmond, M.J., Acheson, A.L., Stricker, E.M. (1981). Partial destruction of noradrenergic terminals is followed by increased tyrosine hydroxylase activity in residual terminals. In: Usdin, E., Weiner, N., Youdim, M.B.H. (eds) Function and Regulation of Monoamine Enzymes: Basic and Clinical Aspects. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06276-8_14

Download citation

Publish with us

Policies and ethics